Once the diagnosis of prostate cancer is made, the physician will review all treatment options available to the patient. Further studies to evaluate the extent or stage of disease may be necessary to assist in making a decision about treatment including imaging studies and biomarker testing.
Prostate cancer treatment options are chosen based on both the cancer itself(low risk, intermediate risk, high risk) and patient factors(age, other health issues and personal preferences). Generally, the treatments available for prostate cancer include the following:
Active Surveillance: Some prostate cancers may not harm a patient over the course of their lifetime and close observation of these low risk cancers is a frequent choice in these situations.
Radical prostatectomy: The surgical removal of the prostate. While there are several ways to perform this operation, the robotically assisted approach is the most common method.
Radiation: This involves the application of an external beam of radiation directed to the prostate and the prostate bed.
Brachytherapy: Radioactive seed implantation. This procedure involves the insertion and removal of needles to place radioactive seeds into the prostate.
Cryotherapy involves the insertion of probes into the prostate and the introduction of liquid nitrogen to produce an ice ball within the prostate designed to destroy prostate tissue.
Hormone therapy: Medication or surgery to inhibit the production of testosterone and therefore slow the growth of prostate cancer.
There are other less common options or options currently being studied for use as well. These can be discussed with your physician. For more information on the diagnosis of prostate cancer and the treatment options available visit the American Cancer Society's Web site.
Education and Support Resources on Prostate Cancer
Urology Clinics of North Texas Web site at www.urologyclinics.com
PROSTATE CANCER TREATMENT GUIDELINES FOR PATIENTS: The National Comprehensive Cancer Network and the American Cancer Society have published guidelines for the treatment of prostate cancer. These guidelines are available at American Cancer Society website.
Prostate Cancer Foundation http://www.pcf.org/
US TOO International, Inc. support group www.ustoo.com.
National Institutes of Health, National Cancer Institute Web site at www.cancer.gov.
Foundations supporting prostate cancer research
American Foundation for Urologic Disease www.afud.org
Foundation for Urology Research and Education, Pat Fulgham, M.D., Director, 214-345-5030
An organization called US TOO International sponsors support groups for men with the diagnosis of prostate cancer. The organization has support groups throughout the country. Most of the support groups meet monthly. Dallas area support groups:
Presbyterian Hospital of Dallas: 214-345-5030
Baylor University Medical Center, Dallas: 214.820.2608
To find out more about this organization, go to the US TOO Web site